SCHEMBL7986522

SCHEMBL7986522

O=c1nc(-c2ccccc2)[nH]c2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 2/20 0.48
PARN O95453 1/20 0.48
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.42
PNP P00491 2/20 0.40
P2RX7 Q99572 1/20 0.40
TNKS O95271 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
ACP1 P24666 1/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 2/20 0.39
MMP13 P45452 1/20 0.39
RAB9A P51151 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974508 0.95 CNOT7 (0.51) CNOT7PARNCYP11B1CYP11B2LMNA
SCHEMBL7984283 0.94 CNOT7 (0.43) CNOT7PARNCYP11B2LMNASMN1; SMN2
SCHEMBL7975271 0.92 CNOT7 (0.56) CNOT7PARNSMN1; SMN2ALDH1A1PNP
SCHEMBL7988736 0.90 ACP1 (0.45) CNOT7PARNCYP11B1CYP11B2LMNA
SCHEMBL7985279 0.90 CNOT7 (0.49) CNOT7PARNLMNASMN1; SMN2KDM4E
SCHEMBL7991406 0.89 CNOT7 (0.49) CNOT7PARNCYP11B1CYP11B2LMNA
SCHEMBL7985168 0.89 KMT2A (0.46) CNOT7PARNCYP11B2ALDH1A1KDM4E
SCHEMBL7984720 0.88 CNOT7 (0.48) CNOT7PARNCYP11B1CYP11B2LMNA
SCHEMBL7989422 0.88 CNOT7 (0.47) CNOT7PARNCYP11B1CYP11B2SMN1; SMN2
SCHEMBL7974418 0.88 CNOT7 (0.39) CNOT7PARNCYP11B1CYP11B2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed